BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19926878)

  • 1. Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK.
    Cervantes D; Crosby C; Xiang Y
    Circ Res; 2010 Jan; 106(1):79-88. PubMed ID: 19926878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling.
    Alvarez-Curto E; Inoue A; Jenkins L; Raihan SZ; Prihandoko R; Tobin AB; Milligan G
    J Biol Chem; 2016 Dec; 291(53):27147-27159. PubMed ID: 27852822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK5 activation by Gq-coupled muscarinic receptors is independent of receptor internalization and β-arrestin recruitment.
    Sánchez-Fernández G; Cabezudo S; García-Hoz C; Tobin AB; Mayor F; Ribas C
    PLoS One; 2013; 8(12):e84174. PubMed ID: 24358341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.
    Szereszewski JM; Pampillo M; Ahow MR; Offermanns S; Bhattacharya M; Babwah AV
    PLoS One; 2010 Sep; 5(9):e12964. PubMed ID: 20886089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
    Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
    Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
    J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
    Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
    J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells.
    Broca C; Quoyer J; Costes S; Linck N; Varrault A; Deffayet PM; Bockaert J; Dalle S; Bertrand G
    J Biol Chem; 2009 Feb; 284(7):4332-42. PubMed ID: 19074139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
    Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
    Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
    Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
    PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
    Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
    Kobayashi H; Narita Y; Nishida M; Kurose H
    Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
    McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
    Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).
    Ramachandran R; Mihara K; Chung H; Renaux B; Lau CS; Muruve DA; DeFea KA; Bouvier M; Hollenberg MD
    J Biol Chem; 2011 Jul; 286(28):24638-48. PubMed ID: 21576245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of β-arrestin2 at Thr
    Cassier E; Gallay N; Bourquard T; Claeysen S; Bockaert J; Crépieux P; Poupon A; Reiter E; Marin P; Vandermoere F
    Elife; 2017 Feb; 6():. PubMed ID: 28169830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor.
    Lecat S; Belemnaba L; Galzi JL; Bucher B
    Cell Signal; 2015 Jul; 27(7):1297-304. PubMed ID: 25817573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
    Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
    J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.